Allarity Therapeutics Inc (ALLR) - Total Liabilities

Latest as of December 2025: $8.43 Million USD

Based on the latest financial reports, Allarity Therapeutics Inc (ALLR) has total liabilities worth $8.43 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Allarity Therapeutics Inc (ALLR) cash flow conversion to assess how effectively this company generates cash.

Allarity Therapeutics Inc - Total Liabilities Trend (2013–2025)

This chart illustrates how Allarity Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. Check Allarity Therapeutics Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.

Allarity Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Allarity Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Sub Sri Thai Public Company Limited BK:SST	Thailand	฿4.62 Billion
Photon Energy N.V. WAR:PEN	Poland	zł218.56 Million
Aurania Resources Ltd V:ARU	Canada	CA$16.68 Million
Tecnisa S.A SA:TCSA3	Brazil	R$782.62 Million
Eureka Design Public Company Limited BK:UREKA	Thailand	฿324.34 Million
N Citron Inc KQ:101400	Korea	₩9.56 Billion
Smart Concrete Public Company Limited BK:SMART	Thailand	฿95.74 Million
AlzeCure Pharma ST:ALZCUR	Sweden	Skr15.93 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Allarity Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Allarity Therapeutics Inc market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.13	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Allarity Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Allarity Therapeutics Inc (2013–2025)

The table below shows the annual total liabilities of Allarity Therapeutics Inc from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	$8.43 Million	-22.23%
2024-12-31	$10.84 Million	-25.83%
2023-12-31	$14.61 Million	+15.48%
2022-12-31	$12.65 Million	-58.98%
2021-12-31	$30.85 Million	+370.83%
2020-12-31	$6.55 Million	-38.79%
2019-12-31	$10.70 Million	+0.17%
2018-12-31	$10.69 Million	+529.09%
2017-12-31	$1.70 Million	+27.11%
2016-12-31	$1.34 Million	+157.91%
2015-12-31	$518.15K	+3489.03%
2014-12-31	$14.44K	+15.01%
2013-12-31	$12.55K	--

About Allarity Therapeutics Inc

NASDAQ:ALLR USA Biotechnology

Market Cap

$20.56 Million

Market Cap Rank

#25322 Global

#5122 in USA

Share Price

$1.30

Change (1 day)

-3.70%

52-Week Range

$0.80 - $1.97

All Time High

$1000000.00